| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |